Prostate Cancer
Tissue composition and density impact on the clinical parameters for 125I prostate implants dosimetry - Abstract
November 8, 2014
Long-term survival of extremely advanced prostate cancer patients diagnosed with prostate-specific antigen over 500 ng/ml - Abstract
November 8, 2014
Quo vadis: Advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies - Abstract
November 8, 2014
From bench to bedside: The realities of reducing global prostate cancer disparity in black men - Abstract
November 6, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancer - Abstract
November 6, 2014
Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer - Abstract
November 6, 2014
Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both - Abstract
November 6, 2014
Gleason drift in the NIHR ProtecT Study - Abstract
November 6, 2014
Current state of prostate cancer treatment in Jamaica - Abstract
November 5, 2014
Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score - Abstract
November 5, 2014
Radiation-induced leiomyosarcoma of the prostate after brachytherapy for prostatic adenocarcinoma - Abstract
November 5, 2014
Sequential treatment with taxanes and novel anti-androgenic compounds in castration-resistant prostate cancer - Abstract
November 5, 2014
Measuring the quality of life in men with prostate cancer - Abstract
November 5, 2014